Pancreaze (Pancrelipase) Market Report 2026

Pancreaze (Pancrelipase) Market Overview

• The Pancreaze (Pancrelipase) market growth in the historic period has been driven by increasing incidence of pancreatic insufficiency, rising prevalence of cystic fibrosis • Market expansion is supported by expansion of long-term digestive disease management, increasing adoption of personalized enzyme dosing • Growth Driver: Cystic Fibrosis Prevalence Surge Fuels Demand For Pancreaze (Pancrelipase) Treatment • Market Trend: Clinical Evidence Strengthening Pancreaze (Pancrelipase) Market Position • North America was the largest region in 2025.

What Is Covered Under Pancreaze (Pancrelipase) Market?

Pancreaze (pancrelipase) is a prescription medication that contains a combination of digestive enzymes, including amylase, lipase, and protease, used to help the body digest food. It is primarily prescribed to individuals with pancreatic insufficiency due to conditions such as cystic fibrosis or chronic pancreatitis. The main types of pancreaze (pancrelipase) are capsules and tablets. The capsule form of Pancreaze (pancrelipase) is designed to be swallowed whole. It contains a powder or granules inside a soft or hard shell that dissolves in the stomach to release the active enzyme. The various ages include children, adults, and geriatrics. The several distribution channels involved are hospital pharmacies, retail pharmacies, and online pharmacies. The various applications are chronic pancreatitis, cystic fibrosis, and other applications.

What Is The Pancreaze (Pancrelipase) Market Growth Forecast?

The pancreaze (pancrelipase) market size is expected to see strong growth in the next few years. It will grow to $2173.57 million in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to expansion of long-term digestive disease management, increasing adoption of personalized enzyme dosing, growing elderly population with digestive disorders, rising awareness of pancreatic enzyme therapies, improvements in oral drug delivery technologies. Major trends in the forecast period include increasing demand for enzyme replacement therapies, rising focus on digestive disorder management, expansion of personalized dosage formulations, growing use of chronic enzyme supplementation, enhanced stability of oral enzyme products.

Global Pancreaze (Pancrelipase) Market Segmentation

1) By Type: Capsule, Tablet 2) By Age: Children, Adults, Geriatric 3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies 4) By Application: Chronic Pancreatitis, Cystic Fibrosis, Other Applications

What Are The Drivers Of The Pancreaze (Pancrelipase) Market?

Rising cystic fibrosis cases are expected to propel the growth of the pancreaze (pancrelipase) market going forward. Cystic fibrosis is a genetic disorder that affects the lungs, digestive system, and other organs by causing the production of thick, sticky mucus, leading to blockages, infections, and impaired function. Rising cystic fibrosis cases are primarily due to increased awareness, better diagnostic techniques, and expanded genetic screening programs, which identify more cases, including milder forms, that previously went undiagnosed. Pancreaze (pancrelipase) is used in cystic fibrosis to aid digestion by replacing the enzymes that the pancreas cannot produce effectively, helping patients absorb nutrients from food and improving overall nutritional health. For instance, in October 2024, according to the Cystic Fibrosis Trust, a UK-based charity dedicated to supporting people with cystic fibrosis, in 2022, 11,148 cystic fibrosis patients were registered, and this number grew to 11,318 in 2023, reflecting a 1.5% increase in patient registrations year-over-year. Therefore, rising cystic fibrosis cases are driving the growth of the pancreaze (pancrelipase) industry. The increase in the incidence of pancreatic conditions will drive the growth of the Pancreaze (pancrelipase) market going forward. Pancreatic conditions refer to disorders that affect the pancreas, including pancreatitis, exocrine pancreatic insufficiency (EPI), pancreatic cancer, and diabetes, which impair its digestive and hormonal functions. The incidence of these conditions is rising as more individuals experience obesity, diabetes, alcohol overuse, smoking-related complications, and benefit from improved diagnostic tools that enable earlier detection. Pancreaze supports clinical management by restoring digestive enzyme levels, improving nutrient absorption, and reducing symptoms such as malnutrition and diarrhea. For instance, in February 2023, according to Cancer Research UK, a UK-based independent cancer research organization, the annual number of new pancreatic cancer cases in the UK is expected to increase from approximately 12,500 cases in 2023-2025 to around 16,000 cases by 2038-2040. This represents a 5% growth in incidence rates over the period, reaching an average of 19 cases per 100,000 people annually by 2038-2040. Therefore, the increase in the incidence of pancreatic conditions will drive the growth of the pancrease (pancrelipase) market.

Key Players In The Global Pancreaze (Pancrelipase) Market

Major companies operating in the pancreaze (pancrelipase) market are AbbVie Inc.

Global Pancreaze (Pancrelipase) Market Trends and Insights

A key trend in the pancreaze (pancrelipase) market is the increasing emphasis on clinical evidence to support drug efficacy, particularly through clinical trial data. This data plays a crucial role in enhancing regulatory approval processes, improving patient outcomes, and strengthening a drug's competitive positioning in the market. For instance, in May 2024, Vivus, Inc., a US-based biopharmaceutical company, announced the publication of new clinical trial data highlighting the efficacy of PANCREAZE (pancrelipase) in stabilizing weight among chemotherapy patients with pancreatic ductal adenocarcinoma (PDAC) suffering from cachexia and exocrine pancreatic insufficiency (EPI). The findings also indicate the potential benefits of PANCREAZE in reducing stool frequency and enhancing stool consistency. The study was conducted as an investigator-initiated trial by researchers at Cedars-Sinai Medical Center and the Samuel Oschin Cancer Center.

Regional Insights

North America was the largest region in the pancreaze (pancrelipase) market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Pancreaze (Pancrelipase) Market?

The pancreaze (pancrelipase) market consists of sales of pancreaze delayed-release capsules, pancreaze powder, and pancreaze oral pellets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pancreaze (Pancrelipase) Market Report 2026?

The pancreaze (pancrelipase) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pancreaze (pancrelipase) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.